Trials (Netherlands Cancer Institute - Antoni van Leeuwenhoek): Revision history

15 December 2025

• curprev 17:0117:01, 15 December 2025‎ Francine talk contribs‎ 175,440 bytes +216‎ No edit summary undo

6 December 2025

• curprev 12:4212:42, 6 December 2025‎ Lucas talk contribs‎ m 175,224 bytes +1,701‎ Update categories. undo

4 December 2025

• curprev 17:2717:27, 4 December 2025‎ Larysse talk contribs‎ 173,523 bytes +56‎ No edit summary undo

2 December 2025

• curprev 14:0014:00, 2 December 2025‎ Lucas talk contribs‎ m 173,467 bytes +90‎ Update categories. undo

5 December 2023

• curprev 18:0918:09, 5 December 2023‎ Francine talk contribs‎ 173,377 bytes +173,377‎ Created page with "{{forpatients}} {{forresearchers}} {{forproviders}} Go back to Netherlands Cancer Institute - Antoni van Leeuwenhoek page '''NCTID''': NCT04614103 '''Title''': Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer '''Study Summary''': This is a prospective, open-label, multi-cohort, non-randomized, multicenter phase 2 study evaluating LN-145 in patients with metastatic non-small-cell lung cancer '''Sponsor''': Iovance Biotherapeutics, Inc...."